1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Cardiovascular Devices Market Trends
Bioabsorbable Stent/Bioresorbable Scaffold Market by Material, Absorption Rate, Application & End User - Global Forecasts to 2022

Bioabsorbable Stent/Bioresorbable Scaffold Market: Global Forecasts until 2022

  • August 2017
  • 140 pages
  • ID: 5077139
In this report:
In 2017, the hospitals segment is expected to command the largest share of ##.##% of the bioresorbable stents market in the U.K. This segment is projected to reach USD ##.## million by 2022 from USD ##.## million in 2017, at a CAGR of ##.##% during the forecast period.
In 2017, the coronary artery disease segment is expected to command the largest share of ##.##% of the bioresorbable stents market in the U.K. This segment is projected to reach USD ##.## million by 2022 from USD ##.## million in 2017, at a CAGR of ##.##% during the forecast period.

Summary

Table of Contents

Search Inside

"Bioresorbable stents market forecasted to grow at a compound annual growth rate (CAGR) of 11.50 percent between 2017 and 2022"

The overall bioresorbable stents market is forecasted to reach $417.20M by 2022 from $223.60M in 2016, at a compound annual growth rate (CAGR) of 11.5% during the forecast horizon. Increasing aging population susceptible to coronary and peripheral artery diseases, growing PCI procedures, growing focus of firms on clinical trials of bioresorbable stents, rising adoption of these stents by physicians and patients, and patients' preference for minimally invasive therapies are factors that are forecast to steer the market rise in future. Nevertheless, the presence of substitutes may restrain the market increase for bioresorbable stents to some extent.

"The coronary artery diseases segment is anticipated to grow at the maximal compound annual growth rate (CAGR) during the estimate period"

Established on application, the sector is divided into coronary artery diseases and peripheral artery diseases. In 2017, coronary artery diseases are anticipated to grow at the highest CAGR (Compound annual growth rate) during the outlook period. This positive increase is assigned to Elements such as increasing aging population prone to coronary artery diseases and the adoption of unhealthy lifestyle habits leading to increased risk of these diseases.

"Hospitals to lead the overall bioresorbable stents market in 2017"

Established on final users, the sector is divided into hospitals and cardiac centers. The hospitals segment is forecasted to dominate the industry. The dominance of this segment is assigned to the growing need of surgeries, increasing risk of CAD and PAD, and enhanced reimbursement scenario for hospitals.

"North America to witness high rise during the estimate period"

In 2017, EU is forecasted to account for the biggest share of the overall bioresorbable stents market. The dominance of European area is assigned to factors such as rising regulatory approvals for stents which will facilitate their commercialization and growing research activities for development of bioresorbable stents. Also, North America (NA) is projected to register the highest compound annual growth rate (CAGR) during the outlook period. The important increase in this regional segment is assigned to the growing prevalence of CAD and PAD, patient preference for minimally invasive therapies, unhealthy lifestyle habits, and huge patient pool are enabling this industry to grow in this area.

The primary interviews conducted for this business report can be categorized as follows:

• By Company category: Tier 1 - 30.0 percent; Tier 2 - 45.0 percent; Tier 3 - 25%.

• By Description : C-level- 25.0 percent; D-level- 30.0 percent; Others- 45%.

• By Area: North America continent - 45.0 percent; Europe (EU) - 35.0 percent; Asia area - 12.0 percent; RoW - 8%.

List of firms decribed in the market research:

• Abbott

• REVA Medical, Incorporated

• Elixir Medical Corporation

• KYOTO MEDICAL PLANNING Co., Limited

• BIOTRONIK

• Amaranth Medical, Incorporated

• Lepu Medical Technology Co., Limited

Research coverage:

The industry report offers an overview of the overall bioresorbable stents market. It aims at evaluating the market value and upcoming growth potential of this market across distinct segments including material, absorption rate, application, final users, and area. Moreover, the study also comprises a detailed competitive analysis of the top players in the sector together with their company descriptions, recent evolutions, and key industries strategies.

Principal benefits of buying the market research:

The analysis will facilitate the market top players/new sector entrants in this sector by providing them with the best approximations of the revenue data for the global overall bioresorbable stents market and its sub-segments. This industry report will facilitate partners to comprehend the competitive landscape better and acquire business insights to position their businesses better and focus on suitable go-to-market approaches. The market research also will help the partners comprehend the pulse of the sector and offer them with info concerning main market drivers, restraints challenges, and alternatives.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2018

Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2018

  • $ 4000
  • Industry report
  • June 2018
  • by GlobalData

Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2018SummaryGlobalData’s Medical Devices sector report, “Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2018" provides ...

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018

  • $ 4000
  • Industry report
  • June 2018
  • by GlobalData

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018SummaryGlobalData’s Medical Devices sector report, “Percutaneous Transluminal Coronary ...

Drug Eluting Stents (DES) - Medical Devices Pipeline Assessment, 2018

Drug Eluting Stents (DES) - Medical Devices Pipeline Assessment, 2018

  • $ 4000
  • Industry report
  • June 2018
  • by GlobalData

Drug Eluting Stents (DES) - Medical Devices Pipeline Assessment, 2018SummaryGlobalData’s Medical Devices sector report, “Drug Eluting Stents (DES) - Medical Devices Pipeline Assessment, 2018" provides ...


Download Unlimited Documents from Trusted Public Sources

Interventional Cardiology Device Industry in the US

  • March 2018
    16 pages
  • Cardiology  

    Hospital  

    Interventional ...  

  • United States  

View report >

Interventional Cardiology Device Industry in India

  • February 2018
    6 pages
  • Interventional ...  

    Hospital  

  • India  

View report >

Cardiovascular Disease Statistics in the US

  • March 2018
  • Cardiovascular ...  

    Cardiac Managem...  

  • United States  

    North America  

View report >

ref:plp2017

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on